Massachusetts Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-85,320
| Closed | -$3.09M | – | 878 |
|
|
2016
Q4 | $3.09M | Sell |
85,320
-13,751
| -14% | -$498K | ﹤0.01% | 693 |
|
|
2016
Q3 | $4.56M | Sell |
99,071
-36,157
| -27% | -$1.66M | ﹤0.01% | 659 |
|
|
2016
Q2 | $6.79M | Sell |
135,228
-551,490
| -80% | -$27.7M | ﹤0.01% | 611 |
|
|
2016
Q1 | $36.7M | Buy |
686,718
+10,389
| +2% | +$556K | 0.02% | 397 |
|
|
2015
Q4 | $44.4M | Buy |
676,329
+196,840
| +41% | +$12.9M | 0.02% | 362 |
|
|
2015
Q3 | $27.1M | Buy |
479,489
+102,301
| +27% | +$5.78M | 0.02% | 438 |
|
|
2015
Q2 | $22.3M | Buy |
377,188
+1,289
| +0.3% | +$76.2K | 0.01% | 498 |
|
|
2015
Q1 | $23.4M | Buy |
375,899
+358,519
| +2,063% | +$22.3M | 0.01% | 490 |
|
|
2014
Q4 | $1,000K | Buy |
17,380
+6,077
| +54% | +$349K | ﹤0.01% | 781 |
|
|
2014
Q3 | $608K | Buy |
11,303
+4,599
| +69% | +$247K | ﹤0.01% | 828 |
|
|
2014
Q2 | $352K | Sell |
6,704
-1,856
| -22% | -$97.5K | ﹤0.01% | 862 |
|
|
2014
Q1 | $452K | Buy |
+8,560
| New | +$452K | ﹤0.01% | 824 |
|
|
2013
Q4 | – | Sell |
-128,298
| Closed | -$4.85M | – | 855 |
|
|
2013
Q3 | $4.85M | Sell |
128,298
-170,790
| -57% | -$6.45M | ﹤0.01% | 610 |
|
|
2013
Q2 | $11.7M | Buy |
+299,088
| New | +$11.7M | 0.01% | 517 |
|